CTA
HALO icon

Carillon Tower Advisers’s Halozyme HALO Stock Holding History

Carillon Tower Advisers’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$56.2M Sell
1,315,654
-66,303
-5% -$2.38M 0.34% 94
2020
Q3 		$36.3M Buy
1,381,957
+88,839
+7% +$2.47M 0.48% 44
2020
Q2 		$34.7M Buy
1,293,118
+240,144
+23% +$5.42M 0.27% 121
2020
Q1 		$17.2M Hold
1,052,974
– – 0.17% 195
2019
Q4 		$18.7M Hold
1,052,974
– – 0.12% 266
2019
Q3 		$16.3M Buy
+1,052,974
New +$17.3M 0.11% 277

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carillon Tower Advisers's HALO Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Halozyme (HALO) stake by 4.8% in Q4 2020, selling an estimated $2.38M and leaving 1,315,654 shares worth $56.2M. The position accounts for 0.34% of the portfolio, ranked #94.

Carillon Tower Advisers first reported a position in HALO in Q3 2019 and has held it in 6 quarters since. 342 funds tracked by Wall St. Rank hold HALO as of Q4 2020.

  • Carillon Tower Advisers held 1,315,654 shares of Halozyme worth $56.2M as of Q4 2020.
  • Carillon Tower Advisers sold 66,303 Halozyme shares in Q4 2020, an estimated $2.38M.
  • Halozyme made up 0.34% of Carillon Tower Advisers's portfolio in Q4 2020, its #94 holding.
  • Carillon Tower Advisers first reported a position in Halozyme in Q3 2019 and has held it in 6 quarters since.
  • 342 funds tracked by Wall St. Rank held Halozyme as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.